• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2021 Fiscal Year Annual Research Report

The role of LILRB4 on MDSC-mediated immunosuppression in tumor environment

Research Project

Project/Area Number 19K16705
Research InstitutionTohoku University

Principal Investigator

蘇 美慈  東北大学, 加齢医学研究所, 助教 (00812116)

Project Period (FY) 2019-04-01 – 2022-03-31
KeywordsLILRB4 / gp49B / MDSC / Immunosuppression / tumor metastasis / miRNA
Outline of Annual Research Achievements

In this study, we report that the leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4, murine ortholog gp49B) orchestrates the polarization of MDSCs to exhibit pro-tumor phenotypes. Our results reveal that LILRB4/gp49B promotes MDSC-mediated tumor metastasis by regulating the M2-polarization of MDSCs and suppressing the secretion of miR-1 family miRNAs, which facilitate tumor migration and invasion. We have published our results on the Oncolmmunology (DOI: 10.1080/2162402X.2022.2060907).

  • Research Products

    (9 results)

All 2022 2021

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 3 results) Presentation (4 results) (of which Int'l Joint Research: 1 results) Patent(Industrial Property Rights) (1 results) Funded Workshop (1 results)

  • [Journal Article] LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs2022

    • Author(s)
      Su Mei-Tzu、Kumata Sakiko、Endo Shota、Okada Yoshinori、Takai Toshiyuki
    • Journal Title

      OncoImmunology

      Volume: 11 Pages: e2060907

    • DOI

      10.1080/2162402X.2022.2060907

    • Peer Reviewed / Open Access
  • [Journal Article] Co-localization of Fibronectin Receptors LILRB4/gp49B and Integrin on Dendritic Cell Surface2022

    • Author(s)
      Takahashi Naoyuki, Itoi Sho, Su Mei-Tzu, Endo Shota, Takai Toshiyuki
    • Journal Title

      Tohoku J Expect Med.

      Volume: - Pages: in press

    • Peer Reviewed / Open Access
  • [Journal Article] Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/<i>Yaa</i> mice2021

    • Author(s)
      Su Mei-Tzu、Inui Masanori、Wong Yi Li、Takahashi Maika、Sugahara-Tobinai Akiko、Ono Karin、Miyamoto Shotaro、Murakami Keiichi、Itoh-Nakadai Ari、Kezuka Dai、Itoi So、Endo Shota、Hirayasu Kouyuki、Arase Hisashi、Takai Toshiyuki
    • Journal Title

      International Immunology

      Volume: 33 Pages: 447~458

    • DOI

      10.1093/intimm/dxab028

    • Peer Reviewed / Open Access
  • [Presentation] Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice2021

    • Author(s)
      Mei-Tzu Su, Masanori Inui, Shota Endo, Kouyuki Hirayasu, Hisashi Arase, Toshiyuki Takai
    • Organizer
      第50回日本免疫学会学術集会 (Web)
  • [Presentation] The immune inhibitory receptor LILRB4/gp49B reduces anti-tumor exosomal miRNA levels in plasma through promoting MDSC-mediated immunosuppression2021

    • Author(s)
      Sakiko Kumata, Mei-Tzu Su, Shota Endo, Toshiyuki Takai
    • Organizer
      第50回日本免疫学会学術集会 (Web)
  • [Presentation] Gp49B-fibronectin interaction negatively regulates osteoclastogenesis2021

    • Author(s)
      Dai Kezuka, Karin Ono, Mei-Tzu Su, Toshiyuki Takai
    • Organizer
      第50回日本免疫学会学術集会 (Web)
  • [Presentation] Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice2021

    • Author(s)
      Mei-Tzu Su, Masanori Inui, Shota Endo, Toshiyuki Takai
    • Organizer
      Virtual IMMUNOLOGY 2021
    • Int'l Joint Research
  • [Patent(Industrial Property Rights)] がん患者の予後を予測するためのバイオマーカー、がん患者の予後を予測するための方法、及び、がん患者の予後を予測するためのキット2021

    • Inventor(s)
      高井俊行、熊田早希子、岡田克典、SU MEI TZU 他
    • Industrial Property Rights Holder
      東北大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      特願2021-119757
  • [Funded Workshop] Virtual IMMUNOLOGY2021 (www.immunology2021.org)2021

URL: 

Published: 2022-12-28  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi